Lung Cancer Trials Ask AI to find trials
RecruitingNot applicableNCT07062172
Official study title

Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer

Study summary

This is a single-armed screening research study which screens immediate family member of lung cancer patients with a driver mutation to see if lung cancer can be inherited and whether researchers can find lung cancer early. Immediate family members of lung cancer patients will be 40-80 years old and screened using a low dose CT scan.

Ask AI to explain this study
Start here

Key things to know

Main goalScreening

This describes the study’s primary purpose.

What is being studiedLow Dose CT Scan

The study team can explain what participation involves.

Who it may be forLung Cancer · Driver Mutation

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Jul 14, 2025 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?University of California, Irvine

Study sponsor

01
Study overview

What this study is about

Purpose
Screening
Study type
Interventional
Phase
Not applicable
Sponsor
University of California, Irvine
Interventions being studied
Diagnostic Test: Low Dose CT Scan
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Cohort A:
  • Current diagnosis of lung cancer with a driver mutation.
  • Known driver mutation (e.g. via NGS, PCR, IHC, FISH, RT-PCR etc.)
  • Able and willing to give informed consent.
  • Able and willing to complete the screening questionnaire. Cohort A:
Reasons someone may not be able to joinExclusion criteria

There are no

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Chao Family Comprehensive Cancer Center University of California, IrvineOrange, California

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jul 14, 2025. Always confirm current availability with the study team.

View original record ↗